DPP-4 inhibitors and glucose homeostasis - From cell to bedside
10.3760/cma.j.issn.1000-6699.2012.06.023
- VernacularTitle:DPP-4抑制剂与血糖稳态——从基础到临床
- Author:
Bo FENG
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus,type 2;
Glucagon-like peptide-1;
DPP-4 inhibitor
- From:
Chinese Journal of Endocrinology and Metabolism
2012;28(6):525-526
- CountryChina
- Language:Chinese
-
Abstract:
Type 2 Diabetes is the consequence of the disturbances of both α- and β-cell secretions.Glucagon-like peptide-1 ( GLP-1 ),which regulates the function of alpha and beta cells,has led to the emergence of a new class of oral anti-diabetic drugs.DPP-4 inhibitors,which increase the concentration of GLP-1 and consequently improve HbAlC,have become a choice for patients in different stages of diabetes.
